Literature DB >> 3585726

Application of moment analysis in assessing rates of absorption for bioequivalency studies.

A J Jackson, M L Chen.   

Abstract

Moment analysis was utilized in the evaluation of equivalency between test and reference formulations with respect to the rate of absorption for four drugs having different pharmacokinetic characteristics. A confidence interval technique was applied to compare the three relevant absorption parameters, that is, peak plasma concentration (Cmax), time to peak plasma concentration (tmax), and mean absorption time (MAT). Equivalence in the absorption rate of drugs was found to be best evaluated by the combined use of MAT, tmax, and Cmax. Use of these parameters for assessing equivalency requires careful interpretation of the results of statistical analysis as well as appropriate consideration of efficacy and safety issues for individual drugs. In addition, the statistical moment method proves to be useful in the assessment of bioequivalency, particularly for drugs with multiple absorption maxima.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3585726     DOI: 10.1002/jps.2600760103

Source DB:  PubMed          Journal:  J Pharm Sci        ISSN: 0022-3549            Impact factor:   3.534


  4 in total

Review 1.  Measures of exposure versus measures of rate and extent of absorption.

Authors:  M L Chen; L Lesko; R L Williams
Journal:  Clin Pharmacokinet       Date:  2001       Impact factor: 6.447

2.  An alternative approach for assessment of rate of absorption in bioequivalence studies.

Authors:  M L Chen
Journal:  Pharm Res       Date:  1992-11       Impact factor: 4.200

Review 3.  Mean time parameters in pharmacokinetics. Definition, computation and clinical implications (Part II).

Authors:  P Veng-Pedersen
Journal:  Clin Pharmacokinet       Date:  1989-12       Impact factor: 6.447

4.  Pharmacokinetics of intravenous and oral cyclophosphamide in the presence of methotrexate and fluorouracil.

Authors:  E A De Bruijn; P H Slee; A T Van Oosterom; D W Lameijer; K J Roozendaal; U R Tjaden
Journal:  Pharm Weekbl Sci       Date:  1988-10-14
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.